Berry / Kim / Damato Clinical Ophthalmic Oncology

Retinoblastoma
3rd Auflage 2019
ISBN: 978-3-030-11123-6
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: Wasserzeichen (»Systemvoraussetzungen)

E-Book, Englisch, 303 Seiten, eBook

Written by internationally renowned experts, the 3rd edition of this six volume textbook provides detailed practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. Supplying the reader with state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible, this book is divided into six volumes: Basic Principles, Eyelid and Conjunctival Tumors, Orbital Tumors, Uveal Tumors, Retinal Tumors, and Retinoblastoma. The information presented enables readers to provide effective patient care using the latest knowledge on ophthalmic oncology and to verify diagnostic conclusions based on comparison with numerous full-color clinical photographs from the authors' private collections, histopathologic microphotographs, imaging studies, and crisp illustrations. Clinical Ophthalmic Oncology's clinically focused and user-friendly format allows for rapid retrieval of information in daily practice and is written for residents, fellows, and any physician involved in the care of patients with ocular or orbital malignancies. Additionally, this edition adds several hundred new images to improve comprehension of procedures and techniques. This volume describes the classification, differential diagnosis, and imaging of retinoblastoma and discusses the most suitable treatment options for different tumor types.?
   

Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center and then completed a fellowship in Ocular Oncology at Children's Hospital Los Angeles. Dr. Berry is the founder of WOO, Women in Ocular Oncology.
Jonathan Kim, MD, is Director of the Retinoblastoma Program, Attending Physician, and Associate Professor of Clinical Surgery at the Keck School of Medicine of USC. Dr. Kim provides clinical expertise in the management of pediatric intraocular tumors. He was trained at Memorial Sloan-Kettering Cancer Center, Jules Stein Eye Institute at UCLA, and the Massachusetts Eye and Ear Infirmary at Harvard Medical School. He is developing new treatment modalities to save the eyes of children with retinoblastoma and is actively engaged in new research projects. Bertil Damato, MD, PhD, is Professor of Ophthalmology and Radiation Oncology and Director of the Ocular Oncology Service at the University of California, San Francisco. Until 2013, he was Consultant Ophthalmologist at the Royal Liverpool University Hospital, where he was Director of the Ocular Oncology Service, which he established in 1993. Dr. Damato has published more than 200 peer-reviewed articles, 68 reviews, 75 book chapters and 6 books, one as single author.
Arun Singh, MD, is Director of the Cole Eye Institute at Cleveland Clinic in the Department of Ophthalmic Oncology. He is also the Series Editor for Springer's Essentials in Ophthalmology series and was the former Editor for The British Journal of Ophthalmology and is the current Editor of Ocular Oncology and Pathology. 

Jesse L. Berry, MDAssistant Professor of Clinical OphthalmologyUSC Roski Eye InstituteChildren's Hospital Los Angeles  Keck School of Medicine of USC1975 Zonal Ave, Los Angeles California, USA Jonathan W. Kim, MDDirector of Retinoblastoma Program, Children's Hospital Los AngelesAssociate Professor of Clinical OphthalmologyDepartment of Ophthalmology USC Roski Eye InstituteKeck School of Medicine of USC1975 Zonal Ave, Los Angeles California, USA Bertil E. Damato, MD, PhD Professor of Ophthalmology and Radiation Oncology University of Oxford Nuffield Department of Clinical Neurosciences John Radcliffe Hospital Oxford, UK?Arun D. Singh, MDProfessor of OphthalmologyEditor, Ocular Oncology and PathologyDirector, Dept. of Ophthalmic OncologyCole Eye Institute, Cleveland Clinic9500 Euclid Avenue, ClevelandOhio, USA

Zielgruppe

Upper undergraduate

Autoren/Hrsg.

Berry, Jesse L.

Kim, Jonathan W.

Damato, Bertil E.

Singh, Arun D.

Inhaltsverzeichnis

Retinoblastoma: Evaluation and DiagnosisDifferential Diagnosis of LeukocoriaRetinoblastoma: Staging and GroupingRetinoblastoma: Incidence and Etiologic Factors                              Retinoblastoma: An International PerspectiveRetinoblastoma TumorigenesisAnimal Models in Retinoblastoma ResearchRetinocytoma or RetinomaRetinoblastoma: Genetic Counseling and TestingRetinoblastoma: Treatment OptionsRetinoblastoma: Focal Therapy – Laser Treatment and CryotherapyRetinoblastoma: Focal Therapies: BrachytherapyRetinoblastoma: Intravenous ChemotherapyIntra-ophthalmic Artery Chemotherapy for RetinoblastomaRetinoblastoma: Intravitreal chemotherapyRetinoblastoma: External beam radiationRetinoblastoma: EnucleationRetinoblastoma: Evolving TherapiesHistopathologic Features and Prognostic FactorsOrbital Retinoblastoma: Diagnosis and ManagementRetinoblastoma: Metastatic DiseaseNon ocular tumors and other long term complicationsTrilateral RetinoblastomaScreening Children at Risk for Retinoblastoma Children’s Oncology Group (COG) Trials for RetinoblastomaSocial Aspects, Advocacy and Organizations            Retinoblastoma: Metastatic DiseaseNon-ocular TumorsTrilateral RetinoblastomaChildren’s Oncology Group (COG) Trials for Retinoblastoma

Über Autor(innen)

Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center and then completed a fellowship in Ocular Oncology at Children’s Hospital Los Angeles. Dr. Berry is the founder of WOO, Women in Ocular Oncology.Jonathan Kim, MD, is Director of the Retinoblastoma Program, Attending Physician, and Associate Professor of Clinical Surgery at the Keck School of Medicine of USC. Dr. Kim provides clinical expertise in the management of pediatric intraocular tumors. He was trained at Memorial Sloan-Kettering Cancer Center, Jules Stein Eye Institute at UCLA, and the Massachusetts Eye and Ear Infirmary at Harvard Medical School. He is developing new treatment modalities to save the eyes of children with retinoblastoma and is actively engaged in new research projects. Bertil Damato, MD, PhD, is Professor of Ophthalmology and Radiation Oncology and Director of the Ocular Oncology Service at the University of California, San Francisco. Until 2013, he was Consultant Ophthalmologist at the Royal Liverpool University Hospital, where he was Director of the Ocular Oncology Service, which he established in 1993. Dr. Damato has published more than 200 peer-reviewed articles, 68 reviews, 75 book chapters and 6 books, one as single author.Arun Singh, MD, is Director of the Cole Eye Institute at Cleveland Clinic in the Department of Ophthalmic Oncology. He is also the Series Editor for Springer's Essentials in Ophthalmology series and was the former Editor for The British Journal of Ophthalmology and is the current Editor of Ocular Oncology and Pathology. Jesse L. Berry, MDAssistant Professor of Clinical OphthalmologyUSC Roski Eye InstituteChildren's Hospital Los Angeles  Keck School of Medicine of USC1975 Zonal Ave, Los AngelesCalifornia, USA Jonathan W. Kim, MDDirector of Retinoblastoma Program, Children's Hospital Los AngelesAssociate Professor of Clinical OphthalmologyDepartment of Ophthalmology USC Roski Eye InstituteKeck School of Medicine of USC1975 Zonal Ave, Los AngelesCalifornia, USABertil E. Damato, MD, PhDProfessor of Ophthalmology and Radiation OncologyUniversity of OxfordNuffield Department of Clinical NeurosciencesJohn Radcliffe HospitalOxford, UKArun D. Singh, MDProfessor of OphthalmologyEditor, Ocular Oncology and PathologyDirector, Dept. of Ophthalmic OncologyCole Eye Institute, Cleveland Clinic9500 Euclid Avenue, ClevelandOhio, USA